SCHEMBL4045481

SCHEMBL4045481

O=C(NC1CCCCC1)C(C1CCCCC1)C1(c2ccc(Cl)nc2)Nc2ccccc2N1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 1/20 0.42
CNR1 P21554 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
EPHX1 P07099 1/20 0.38
NR1H4 Q96RI1 2/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPT P10636 1/20 0.37
HTT P42858 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
TSHR P16473 2/20 0.37
POLB P06746 1/20 0.37
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 1/20 0.36
ACKR3 P25106 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4041338 0.87 SMN1; SMN2 (0.41) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL4039101 0.87 NR1H4 (0.44) MDM2NPC1RAB9ASMN1; SMN2EPHX1
SCHEMBL4042732 0.87 NR1H4 (0.44) MDM2NPC1RAB9ASMN1; SMN2EPHX1
SCHEMBL4044583 0.86 NR1H4 (0.42) CNR1NPC1RAB9ASMN1; SMN2EPHX1
SCHEMBL4034866 0.85 EPHX1 (0.39) MDM2CNR1NPC1RAB9ASMN1; SMN2
SCHEMBL4034826 0.85 GRM5 (0.40) NPC1RAB9ASMN1; SMN2NR1H4ALDH1A1
SCHEMBL4040480 0.84 NR1H4 (0.44) NPC1RAB9ASMN1; SMN2EPHX1NR1H4
SCHEMBL4044540 0.84 NR1H4 (0.44) NPC1RAB9ASMN1; SMN2EPHX1NR1H4
SCHEMBL4042940 0.84 TSHR (0.45) NPC1RAB9ASMN1; SMN2EPHX1ALDH1A1
SCHEMBL4040656 0.84 LMNA (0.45) CNR1NPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed